Chesapeake Urology Research Associates

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Prostate cancer3 trials
• Bladder cancer2 trials

Phase

• Phase 13 trials
• Phase 32 trials

Status

• Completed4 trials
• Active, not recruiting1 trial

Lead sponsor

• Protara Therapeutics2 trials
• Candel Therapeutics, Inc.1 trial
• Pfizer1 trial
• Sumitomo Pharma America, Inc.1 trial

Running trials

• Active, not recruiting

  Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer

  NCT01436968· Phase 3· Candel Therapeutics, Inc.· Source

Closed trials

• Completed

  Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)

  NCT05085990· Phase 1· Protara Therapeutics· Source

• Completed

  Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)

  NCT05085977· Phase 1· Protara Therapeutics· Source

• Completed

  Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer

  NCT04666129· Phase 1· Sumitomo Pharma America, Inc.· Source

• Completed

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· Phase 3· Pfizer· Source